In particular, we found the downregulation of lnc-LTBP3-2 located at 11q13 antisense to both NEAT1 and MALAT1, the latter being a well-known putative oncogenic lncRNA found significantly correlated with lnc-LTBP3-2 expression in our CLL data set (R=0.54, P<2.2e-16). This evidence concerns the gene NEAT1 and B-cell chronic lymphocytic leukemia.